Lesson · 40 min · Free
Phase II Drug Metabolism
Phase II Drug Metabolism body { font-family: sans-serif; line-height: 1.6; color: #333; max-width: 900px; margin: 20px auto; padding: 0 15px; } h1, h2 { color: #0056b3; } h1 { border-bottom: 2px solid #0056b3; padding-bo
Pharmacokinetics & Drug Metabolism: Phase II Drug Metabolism
Welcome to this lesson on Phase II Drug Metabolism, a critical component of drug disposition in the body. While Phase I reactions often introduce or expose polar functional groups, Phase II reactions take these modified or naturally polar compounds and conjugate them with endogenous, highly polar molecules. This conjugation significantly increases the compound's hydrophilicity, making it much easier to excrete via urine or bile. These reactions are primarily anabolic, meaning they build larger molecules from smaller ones, and are generally detoxification pathways, although bioactivation can occasionally occur. Phase II reactions are catalyzed by a family of enzymes known as transferases, as they transfer a group from an activated endogenous cosubstrate to the drug molecule. The most common and clinically significant Phase II reactions include glucuronidation, sulfation, acetylation, methylation, and glutathione conjugation. Understanding these pathways is crucial for predicting drug-drug interactions, explaining variability in drug response, and designing prodrugs.
Key Conjugation Pathways
Let's delve into the major Phase II conjugation pathways:
Glucuronidation
Glucuronidation is arguably the most common and quantitatively significant Phase II pathway. It involves the transfer of glucuronic acid from UDP-glucuronic acid (UDPGA) to a substrate molecule. This reaction is catalyzed by a superfamily of enzymes called UDP-glucuronosyltransferases (UGTs). UGTs are primarily located in the endoplasmic reticulum of hepatocytes, but are also found in other tissues like the kidney, gastrointestinal tract, and skin. Substrates for glucuronidation include hydroxyl groups (phenols, alcohols), carboxyl groups, amines, and thiols. The resulting glucuronide conjugates are highly polar, often anionic, and readily excreted. A classic example is the metabolism of paracetamol (acetaminophen): Paracetamol + UDP-glucuronic acid --(UGT)--> Paracetamol Glucuronide + UDP This reaction detoxifies paracetamol by converting it into a readily excretable metabolite. Impairment of glucuronidation can lead to drug accumulation and toxicity, as seen in neonates with underdeveloped UGT systems or individuals with genetic polymorphisms in UGT enzymes (e.g., Gilbert's syndrome affecting UGT1A1).
Sulfation
Sulfation involves the transfer of a sulfonate group (SO 3 - ) from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to a substrate. This reaction is catalyzed by sulfotransferases (SULTs), which are cytosolic enzymes found in various tissues, including the liver, kidney, and intestine. Phenols, alcohols, and amines are common substrates for sulfation. Like glucuronidation, sulfation generally increases hydrophilicity and promotes excretion. Consider the sulfation of a phenolic compound: Phenol + PAPS --(SULT)--> Phenyl Sulfate + PAP Sulfation pathways can become saturated at higher drug concentrations due to limited intracellular PAPS availability, leading to a shift towards other metabolic pathways, such as glucuronidation for drugs like paracetamol. This saturation kinetics is an important consideration in toxicology.
Acetylation
Acetylation involves the transfer of an acetyl group from acetyl coenzyme A (acetyl-CoA) to a substrate. This reaction is catalyzed by N-acetyltransferases (NATs), which are cytosolic enzymes. Primary amines (e.g., aromatic amines, hydrazines) are the main substrates for acetylation. NATs exhibit significant genetic polymorphism, leading to "fast acetylator" and "slow acetylator" phenotypes, which can dramatically affect drug efficacy and toxicity. An example is the acetylation of isoniazid, an antitubercular drug: Isoniazid + Acetyl-CoA --(NAT2)--> N-acetylisoniazid + CoA Slow acetylators are prone to higher plasma concentrations of isoniazid and increased risk of peripheral neuropathy, while fast acetylators may require higher doses to achieve therapeutic effects.
Methylation
Methylation involves the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a substrate. This reaction is catalyzed by methyltransferases, which are found in both the cytosol and endoplasmic reticulum. Substrates include catechols, phenols, amines, and thiols. Methylation generally decreases the polarity of a compound and can sometimes lead to bioactivation or inactivation. For example, the methylation of catecholamines by catechol-O-methyltransferase (COMT) is a significant inactivation pathway: Dopamine + SAM --(COMT)--> 3-Methoxytyramine + S-adenosyl-homocysteine Methylation is also important in the metabolism of endogenous compounds and in the inactivation of certain drugs (e.g., thiopurines by thiopurine methyltransferase, TPMT).
Glutathione Conjugation
Glutathione (GSH) conjugation involves the transfer of the tripeptide glutathione to an electrophilic center on a drug or metabolite. This reaction is catalyzed by glutathione S-transferases (GSTs), which are cytosolic and microsomal enzymes. This pathway is particularly crucial for detoxifying reactive electrophilic intermediates, which are often formed during Phase I metabolism (e.g., epoxides, quinones). The resulting glutathione conjugates are further processed into mercapturic acids, which are readily excreted in urine. The conjugation of an epoxide, a common reactive intermediate: Epoxide + GSH --(GST)--> Glutathione conjugate This pathway is vital for protecting cells from oxidative stress and electrophilic damage. Depletion of GSH can lead to increased toxicity from reactive metabolites, as seen in paracetamol overdose where the toxic N-acetyl-p-benzoquinone imine (NAPQI) is normally detoxified by GSH.
Amino Acid Conjugation
Less common but still significant, amino acid conjugation involves the formation of an amide bond between a carboxylic acid functional group on a drug and the amino group of an amino acid (e.g., glycine, glutamine). This reaction typically involves activation of the carboxylic acid to an acyl-CoA intermediate. It primarily occurs with carboxylic acid-containing drugs. In summary, Phase II reactions are essential for rendering drugs and their Phase I metabolites more water-soluble, thus facilitating their elimination from the body. The interplay between Phase I and Phase II enzymes, as well as genetic and environmental factors influencing their activity, dictates the overall pharmacokinetic profile and potential toxicity of a drug.
Key Takeaways:
Phase II reactions are conjugation reactions that attach large, polar endogenous molecules to drugs or their Phase I metabolites. The primary goal is to increase hydrophilicity for easier renal or biliary excretion. Major pathways include glucuronidation, sulfation, acetylation, methylation, and glutathione conjugation . Enzymes involved are transferases (UGTs, SULTs, NATs, Methyltransferases, GSTs). These pathways are crucial for detoxification , but can also lead to bioactivation or genetic polymorphisms affecting drug response. Co-substrates (e.g., UDPGA, PAPS, Acetyl-CoA, SAM, GSH) are essential and can be rate-limiting.
Practice Exercise:
A new drug candidate, "Drug X," is a weak acid with a phenolic hydroxyl group and an aromatic primary amine. Preliminary in vitro studies suggest it undergoes extensive metabolism. Based on your knowledge of Phase II reactions: Identify at least three major Phase II conjugation pathways Drug X is likely to undergo, justifying your choices based on its functional groups. For one of the identified pathways, describe the enzyme(s) involved, the endogenous co-substrate required, and the general effect on Drug X's polarity and excretability. If a patient is a "slow acetylator," how might this impact the pharmacokinetics and potential toxicity of Drug X, assuming acetylation is a significant pathway for its elimination?
Watch the full lesson — free
This topic is part of Pharmacokinetics & Drug Metabolism, a complete AI-narrated video course. Press play once and watch the entire lecture like a movie.
Start the course free →